ALLMedicine™ Monoclonal Gammopathies Center
Research & Reviews 59 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810195
BMC Cancer; Minarik J, Pika T et. al.
Jan 16th, 2021 - We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RRMM) in the routin...
https://doi.org/10.1111/jns.12405
Journal of the Peripheral Nervous System : JPNS REFERENCES; Briani C, Visentin A et. al.
Jul 20th, 2020 - The peripheral nervous system may be involved at any stage in the course of several hematological diseases, the most common being monoclonal gammopathies (of undetermined significance or malignant) or lymphomas. The underlying pathogenic mechanism...
https://doi.org/10.1093/clinchem/hvz041
Clinical Chemistry; Zajec M, Langerhorst P et. al.
Feb 7th, 2020 - Monoclonal gammopathies (MGs) are plasma cell disorders defined by the clonal expansion of plasma cells, resulting in the characteristic excretion of a monoclonal immunoglobulin (M-protein). M-protein detection and quantification are integral part...
https://doi.org/10.1515/cclm-2019-1105
Clinical Chemistry and Laboratory Medicine; Jacobs JFM, Turner KA et. al.
Jan 15th, 2020 - Background Electrophoretic methods to detect, characterize and quantify M-proteins play an important role in the management of patients with monoclonal gammopathies (MGs). Significant uncertainty in the quantification and limit of detection (LOD) ...
https://doi.org/10.1016/j.retram.2019.11.003
Current Research in Translational Medicine; Belouni R, Allam I et. al.
Nov 25th, 2019 - Plasma cell dyscrasias (PCD) are a heterogeneous group of diseases characterized by the expansion of monoclonal bone marrow plasma cells that produce a monoclonal immunoglobulin (M-component). This is a retrospective study that describes the epide...
Clinicaltrials.gov 61 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810195
BMC Cancer; Minarik J, Pika T et. al.
Jan 16th, 2021 - We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RRMM) in the routin...
https://doi.org/10.1111/jns.12405
Journal of the Peripheral Nervous System : JPNS REFERENCES; Briani C, Visentin A et. al.
Jul 20th, 2020 - The peripheral nervous system may be involved at any stage in the course of several hematological diseases, the most common being monoclonal gammopathies (of undetermined significance or malignant) or lymphomas. The underlying pathogenic mechanism...
https://doi.org/10.1093/clinchem/hvz041
Clinical Chemistry; Zajec M, Langerhorst P et. al.
Feb 7th, 2020 - Monoclonal gammopathies (MGs) are plasma cell disorders defined by the clonal expansion of plasma cells, resulting in the characteristic excretion of a monoclonal immunoglobulin (M-protein). M-protein detection and quantification are integral part...
https://doi.org/10.1515/cclm-2019-1105
Clinical Chemistry and Laboratory Medicine; Jacobs JFM, Turner KA et. al.
Jan 15th, 2020 - Background Electrophoretic methods to detect, characterize and quantify M-proteins play an important role in the management of patients with monoclonal gammopathies (MGs). Significant uncertainty in the quantification and limit of detection (LOD) ...
https://doi.org/10.1016/j.retram.2019.11.003
Current Research in Translational Medicine; Belouni R, Allam I et. al.
Nov 25th, 2019 - Plasma cell dyscrasias (PCD) are a heterogeneous group of diseases characterized by the expansion of monoclonal bone marrow plasma cells that produce a monoclonal immunoglobulin (M-component). This is a retrospective study that describes the epide...
